07.08.2013 22:01:00
|
Hologic to Present at Two Upcoming Investor Conferences
BEDFORD, Mass., Aug. 7, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that Jack W. Cumming, President and Chief Executive Officer, will present at the following conferences:
- Canaccord Genuity 33rd Annual Growth Conference in Boston, Massachusetts on Wednesday, August 14, 2013 at 8 a.m. Eastern Time.
- Morgan Stanley Global Healthcare Conference in New York City, New York on Tuesday, September 10, 2013 at 12:55 p.m. Eastern Time.
Interested parties are invited to listen to the live audio webcasts of the investor presentations on the investor section of Hologic's website at www.hologic.com/investors-overview. Archives of the presentations will be available for replay following the conferences.
About Hologic, Inc.:
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.
Contacts: | |
Deborah R. Gordon | Al Kildani |
Vice President, Investor Relations | Senior Director, Investor Relations |
(781) 999-7716 | (858) 410-8653 |
SOURCE Hologic, Inc.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Hologic IncShsmehr Nachrichten
25.11.24 |
S&P 500-Papier Hologic-Aktie: So viel Gewinn hätte ein Investment in Hologic von vor 10 Jahren eingebracht (finanzen.at) | |
18.11.24 |
S&P 500-Wert Hologic-Aktie: So viel Gewinn hätte ein Investment in Hologic von vor 5 Jahren eingebracht (finanzen.at) | |
11.11.24 |
S&P 500-Papier Hologic-Aktie: So viel hätten Anleger mit einem Investment in Hologic von vor 3 Jahren verdient (finanzen.at) | |
05.11.24 |
Freundlicher Handel in New York: S&P 500 zum Handelsende im Aufwind (finanzen.at) | |
05.11.24 |
Pluszeichen in New York: S&P 500 präsentiert sich am Dienstagnachmittag fester (finanzen.at) | |
05.11.24 |
Gute Stimmung in New York: S&P 500-Börsianer greifen zum Start zu (finanzen.at) | |
04.11.24 |
S&P 500-Papier Hologic-Aktie: So viel Gewinn hätte ein Hologic-Investment von vor einem Jahr abgeworfen (finanzen.at) | |
28.10.24 |
S&P 500-Titel Hologic-Aktie: So viel Gewinn hätte eine Hologic-Investition von vor 10 Jahren eingebracht (finanzen.at) |